As a Condition of Acquiring Meda, FTC Requires Mylan to Sell Rights to Two Generic Drugs
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Mylan Inc.’s $7.2 billion acquisition of Swedish drug maker Meda would likely be...